MS4A1 and cancer: Strikingly, consistent with our findings in HNSCC, Cox-regression analyses also revealed the lack of prognostic power of quantitative CD20 protein levels across pan-cancers, except for two gastrointestinal tract cancers, namely PAAD and STAD.